This topic contains a solution. Click here to go to the answer

Author Question: A person whose lowest WAIS-IV subtest scores are Picture Completion, Block Design, and Matrix ... (Read 110 times)

Awilson837

  • Hero Member
  • *****
  • Posts: 509
A person whose lowest WAIS-IV subtest scores are Picture Completion, Block Design, and Matrix Reasoning most clearly has a relative weakness in
 
  a. long-term memory.
  b. verbal comprehension.
  c. perceptual reasoning.
  d. mathematical ability.

Question 2

Which of the following statements regarding WAIS-IV subtests is FALSE?
 
  a. The Vocabulary subtest contributes to the Verbal Comprehension Index Score.
  b. The Coding subtest contributes to the Processing Speed Index Score
  c. The Matrix Reasoning subtest contributes to the Perceptual Reasoning Index Score.
  d. none of the above



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

mcabuhat

  • Sr. Member
  • ****
  • Posts: 344
Answer to Question 1

C

Answer to Question 2

D




Awilson837

  • Member
  • Posts: 509
Reply 2 on: Jun 21, 2018
:D TYSM


amit

  • Member
  • Posts: 364
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Medication errors are three times higher among children and infants than with adults.

Did you know?

Interferon was scarce and expensive until 1980, when the interferon gene was inserted into bacteria using recombinant DNA technology, allowing for mass cultivation and purification from bacterial cultures.

Did you know?

The effects of organophosphate poisoning are referred to by using the abbreviations “SLUD” or “SLUDGE,” It stands for: salivation, lacrimation, urination, defecation, GI upset, and emesis.

Did you know?

Serum cholesterol testing in adults is recommended every 1 to 5 years. People with diabetes and a family history of high cholesterol should be tested even more frequently.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library